These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9829727)

  • 41. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
    Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
    Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual silencing of epidermal growth factor and insulin-like growth factor 1 receptors significantly limits growth of nasopharyngeal carcinoma in nude mice.
    Zhou X; Yuan Y; Song J; Chen W; Li J; Ye L; Meng X; Xia D
    J Laryngol Otol; 2009 Feb; 123(2):208-22. PubMed ID: 18452630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L; Fauconnet S; Lamielle F; Adessi GL
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variation in agar growth of transformed 3T3 cells after tumor formation in nude mice.
    Romerdahl CA; Rubin H
    J Natl Cancer Inst; 1985 Jun; 74(6):1247-53. PubMed ID: 3889458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of a tumor cell line and its use for an agar-free colony-forming assay.
    Nissen E; Kunde D; Arnold W; Buchmann EF; Tanneberger S
    Neoplasma; 1987; 34(5):563-71. PubMed ID: 3696298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Spontaneous reversion of tumor cells as a source of dormant metastases].
    Lavrovskiĭ VA; Subkhankulova TN
    Tsitologiia; 1998; 40(4):291-301. PubMed ID: 9644762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The IGF-I receptor: a new antiproliferative marker?].
    Fehmann HC; Staats P; Göke B
    Z Gastroenterol; 1995 Oct; 33(10):630-1. PubMed ID: 7502562
    [No Abstract]   [Full Text] [Related]  

  • 50. Antitumor effects of novel shorter truncated insulin-like growth factor I receptors.
    Ojima Y; Hongo A; Liu Y; Zhu L; Kusumoto T; Nakamura K; Seki N; Hiramatsu Y
    Cancer Biol Ther; 2012 May; 13(7):559-66. PubMed ID: 22406993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.
    Prager D; Li HL; Asa S; Melmed S
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2181-5. PubMed ID: 8134369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth of cell colonies in soft agar from biopsies of different human solid tumors.
    Pavelic ZP; Slocum HK; Rustum YM; Creaven PJ; Nowak NJ; Karakousis C; Takita H; Mittelman A
    Cancer Res; 1980 Nov; 40(11):4151-8. PubMed ID: 7471056
    [No Abstract]   [Full Text] [Related]  

  • 53. [Dominant negative IGF-I receptor ].
    Adachi Y; Min Y; Yamamoto H; Imai K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():500-4. PubMed ID: 14574944
    [No Abstract]   [Full Text] [Related]  

  • 54. Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3.
    Kim TY; Lee KH; Chang S; Chung C; Lee HW; Yim J; Kim TK
    J Biol Chem; 2003 Apr; 278(17):15272-8. PubMed ID: 12582166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the insulin-like growth factor I receptor in transformation and apoptosis.
    Resnicoff M; Baserga R
    Ann N Y Acad Sci; 1998 Apr; 842():76-81. PubMed ID: 9599296
    [No Abstract]   [Full Text] [Related]  

  • 56. Systems for identifying new drugs are often faulty.
    Gura T
    Science; 1997 Nov; 278(5340):1041-2. PubMed ID: 9381203
    [No Abstract]   [Full Text] [Related]  

  • 57. Tumor cell growth and cell kinetics.
    Lind J
    Semin Oncol Nurs; 1992 Feb; 8(1):3-9. PubMed ID: 1546216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [In vitro culture: from tissue to cell line].
    Knüchel R; Hofstädter F
    Pathologe; 1994 Jun; 15(3):141-9. PubMed ID: 8072948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of tumor growth by dominant negative inhibition of growth factor receptor signals.
    Ullrich A
    Restor Neurol Neurosci; 1995 Jan; 8(1):75-6. PubMed ID: 21551812
    [No Abstract]   [Full Text] [Related]  

  • 60. IGF-I and Hyaluronic Acid Mitigate the Negative Effect of Irradiation on Human Skin Keratinocytes.
    Sörgel CA; Schmid R; Stadelmann N; Weisbach V; Distel L; Horch RE; Kengelbach-Weigand A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.